Abstract
This second European School of Oncology Monograph on Drug Delivery covers some major fields of theoretical and clinical importance that were only touched upon or even left aside at our first Task Force meeting. We now hope to share with the reader the basis for our stimulating discussions on new therapeutical modalities and to present a survey of the literature, thereby revealing at least one area of surprising ignorance. The latter is probably explained by a communication gap between the manufacturers of drugs and delivery systems and clinical researchers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Domellöf, L. (1989). Introduction. In: Domellöf, L. (eds) Drug Delivery in Cancer Treatment II. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74709-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-74709-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74711-3
Online ISBN: 978-3-642-74709-0
eBook Packages: Springer Book Archive